Skip to main content
Novartis
language-selector-globe
Choose location
language-selector-globeCanada | en
EnglishFrançais
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Albania | English
Albania | Shqip
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose location
language-selector-globeCanada
EnglishFrançais
Americas Asia Pacific Europe International Middle East & Africa
Albania | English
Albania | Shqip
Argentina | Español
Australia | English
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
United States | English
    • About 
      • Novartis in Canada 
      • Diversity, Equity and Inclusion 
      • Executive Committee 
      • People and Culture 
      • Therapeutic Areas 
      • Products 
      • Our people Stories 
      • Contact Us 
      Novartis office
      About
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Adverse Event Reporting 
      • Diseases 
      • Patient perspective Stories 
      Patients and Caregivers
      Patients and Caregivers
    • Healthcare Professionals 
      • HCP Portal 
      • Products 
      • Pipeline (EN) 
      • Adverse Event Reporting 
      • Clinical Trials 
      • Novartis Clinical Trials 
      • Disclosure Of Payments To Healthcare Professionals 
      Healthcare Professionals Header Image
      Healthcare Professionals
    • ESG 
      • Access 
      • Ethics, Risk and Compliance 
      • Grants and Donations 
      • Health Equity Initiative 
        • Guidelines and Eligibility Criteria 
        • About the Novartis Health Equity Initiative 
      • Corporate Responsibility 
        • AODA Compliant - EN (PDF 0.2 MB) 
        • AODA Compliant - FR (PDF 0.2 MB) 
        • AMA Compliant - EN (PDF 0.2 MB) 
        • AMA Compliant - FR (PDF 0.2 MB)  
        • Disclosure Of Payments To Healthcare Professionals 
        • Environmental Sustainability 
      • Reporting and Transparency Hub 
      • Human Rights 
      Environment, Society and Governance
      ESG
    • News 
      • News Archive 
      • Our people Stories 
    • Careers 
      • Diversity, Equity and Inclusion 
      • People and Culture 
      • Career Search 
      • How We Work 
      • Well-being 
      • Our People 
      Two women chatting
      Careers
    • Privacy 
      • Website Privacy Policy 
      • General Privacy Notice for Business Partners 
      • General Privacy Notice for Third Parties 
      • General Privacy Notice for External Stakeholders 
      • Privacy Notice for Pharmacovigilance, Medical Information, and Product Quality Complaints 
    • Contact Us 
    Office call pods
    Contact Us
Global Impact

Global Impact

  1. Home
  2. Stories
  3. Global Impact
Tags Archive Navigation
  • All
  • Careers
  • Feature News
  • In the News
  • Media Releases
icon
  • Story
    Jun 10, 2025
    NOYCIA recognizes Canadian oncology research excellence
  • Story
    Aug 21, 2024
    Enabling early detection of psoriatic arthritis
  • Story
    Aug 21, 2024
    Biomarker research to help modernize care in multiple sclerosis
  • Story
    Aug 21, 2024
    My Krew
  • Story
    Jul 17, 2020
    Mobilizing to meet the COVID-19 challenge
  • Story
    Jun 17, 2019
    International Volunteer Program 2019
  • Story
    Jun 07, 2018
    Novartis employees give back to their communities
  • Story
    Feb 14, 2018
    International Volunteer Program 2018
  • Story
    Nov 15, 2017
    Painting a picture of my patients’ psoriasis
  • Story
    Nov 02, 2017
    2017 Ride for Life
  • Story
    Jun 21, 2017
    Community Partnership Day 2017
  • Story
    Apr 25, 2017
    Novartis rides for cancer

Pagination

  • ‹ Previous page
  • 1
  • 2
  • › Next page

Novartis Canada

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • Careers
Media Center
  • News Archive
  • Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Other Novartis Websites
  • Global site
  • HCP Portal
Footer Bottom
© 2026 Novartis AG
  • Terms of Use
  • Privacy
  • Web Accessibility
  • Cookie Settings
  • Site Map
Novartis Site Directory
This site is intended for an audience in Canada.